D.A. Davidson & Co. Astrazeneca PLC Transaction History

D.A. Davidson & Co.

$13.8 Billion
Q2 2025

A detailed history of D.A. Davidson & Co. transactions in Astrazeneca PLC stock. As of the latest transaction made, D.A. Davidson & Co. holds 37,163 shares of AZN stock, worth $3.12 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

37,163

Previous 36,054 3.08%

Holding current value

$3.12 Million

Previous $2.65 Million 2.0%

% of portfolio

0.02%

Previous 0.02%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 30, 2025	BUY	$64.87 - $75.0 $71,940 - $83,175	1,109 Added 3.08%	37,163 $2.6 Million
Q1 2025 Apr 28, 2025	SELL	$65.37 - $77.96 $4,052 - $4,833	-62 Reduced 0.17%	36,054 $2.65 Million
Q4 2024 Jan 31, 2025	BUY	$63.2 - $79.58 $648,242 - $816,252	10,257 Added 39.67%	36,116 $2.37 Million
Q3 2024 Nov 13, 2024	SELL	$76.67 - $87.62 $600,709 - $686,502	-7,835 Reduced 23.25%	25,859 $2.01 Million
Q2 2024 Jul 31, 2024	BUY	$66.81 - $80.83 $196,087 - $237,236	2,935 Added 9.54%	33,694 $2.63 Million
Q1 2024 May 13, 2024	SELL	$61.03 - $69.57 $45,955 - $52,386	-753 Reduced 2.39%	30,759 $2.08 Million
Q4 2023 Feb 09, 2024	BUY	$61.89 - $69.28 $388,607 - $435,009	6,279 Added 24.88%	31,512 $2.12 Million
Q3 2023 Nov 08, 2023	BUY	$64.85 - $71.7 $117,573 - $129,992	1,813 Added 7.74%	25,233 $1.71 Million
Q2 2023 Aug 10, 2023	SELL	$69.91 - $75.81 $3,914 - $4,245	-56 Reduced 0.24%	23,420 $1.68 Million
Q1 2023 Apr 25, 2023	SELL	$63.15 - $71.6 $103,944 - $117,853	-1,646 Reduced 6.55%	23,476 $1.63 Million
Q4 2022 Feb 03, 2023	BUY	$54.21 - $70.44 $20,979 - $27,260	387 Added 1.56%	25,122 $1.7 Million
Q3 2022 Nov 07, 2022	BUY	$53.02 - $135.75 $172,527 - $441,730	3,254 Added 15.15%	24,735 $1.36 Million
Q2 2022 Jul 28, 2022	BUY	$59.26 - $71.14 $103,823 - $124,637	1,752 Added 8.88%	21,481 $1.42 Million
Q1 2022 May 12, 2022	BUY	$55.72 - $67.12 $42,235 - $50,876	758 Added 4.0%	19,729 $1.31 Million
Q4 2021 Jan 31, 2022	SELL	$54.02 - $63.83 $33,114 - $39,127	-613 Reduced 3.13%	18,971 $1.11 Million
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $103,619 - $113,373	1,865 Added 10.53%	19,584 $1.18 Million
Q2 2021 Aug 10, 2021	BUY	$48.42 - $60.18 $53,068 - $65,957	1,096 Added 6.59%	17,719 $1.06 Million
Q1 2021 May 07, 2021	SELL	$47.16 - $54.44 $29,710 - $34,297	-630 Reduced 3.65%	16,623 $827,000
Q4 2020 Feb 10, 2021	SELL	$48.52 - $58.02 $291 - $348	-6 Reduced 0.03%	17,253 $865,000
Q3 2020 Nov 02, 2020	BUY	$53.07 - $61.1 $56,837 - $65,438	1,071 Added 6.62%	17,259 $946,000
Q2 2020 Aug 10, 2020	SELL	$43.1 - $55.31 $6,292 - $8,075	-146 Reduced 0.89%	16,188 $856,000
Q1 2020 May 05, 2020	SELL	$37.79 - $51.33 $46,443 - $63,084	-1,229 Reduced 7.0%	16,334 $728,000
Q4 2019 Feb 14, 2020	SELL	$42.46 - $50.46 $17,408 - $20,688	-410 Reduced 2.28%	17,563 $877,000
Q3 2019 Nov 05, 2019	BUY	$40.12 - $45.47 $7,341 - $8,321	183 Added 1.03%	17,973 $801,000
Q2 2019 Aug 13, 2019	SELL	$37.28 - $41.68 $100,395 - $112,244	-2,693 Reduced 13.15%	17,790 $734,000
Q1 2019 May 13, 2019	SELL	$35.49 - $43.02 $374,525 - $453,990	-10,553 Reduced 34.0%	20,483 $821,000
Q4 2018 Jan 29, 2019	SELL	$36.86 - $41.49 $59,160 - $66,591	-1,605 Reduced 4.92%	31,036 $1.18 Million
Q3 2018 Nov 13, 2018	BUY	$34.76 - $39.72 $42,615 - $48,696	1,226 Added 3.9%	32,641 $1.29 Million
Q2 2018 Aug 02, 2018	BUY	$34.55 - $37.05 $406,066 - $435,448	11,753 Added 59.78%	31,415 $1.1 Million
Q1 2018 May 04, 2018	BUY	$32.97 - $36.63 $38,014 - $42,234	1,153 Added 6.23%	19,662 $688,000
Q4 2017 Feb 08, 2018	BUY	$32.09 - $34.78 $61,965 - $67,160	1,931 Added 11.65%	18,509 $642,000
Q3 2017 Nov 08, 2017	BUY	$28.96 - $34.0 $31,595 - $37,094	1,091 Added 7.04%	16,578 $561,000
Q2 2017 Aug 11, 2017	BUY	N/A	15,487	15,487 $0

Others Institutions Holding AZN

# of Institutions

1,421

Shares Held

498M

Call Options Held

7.11M

Put Options Held

2.57M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $260B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

News

Stay updated on D.A. Davidson & Co. with notifications on news.

Account